Observational studyFrontiers in immunology2026
Real-world effectiveness and safety of 200 mg abrocitinib initiation in Chinese adults with moderate-to-severe atopic dermatitis: a retrospective study.
Peilin Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.